BridgeMD
New treatment option for Suspected Malignant Lung Neoplasm
Official title First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.
ClinicalTrials.gov ID: NCT06946498
What this study is testing
- What it's testing
- Non randomized study with two groups. The study group includes patients with suspected malignant pleural effusion, in whom the investigation of pleural effusion begins directly with pleural biopsy by Local Anesthesia Thoracoscopy (LAT).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Undiagnosed pleural effusion with the character of a lymphocytic exudate
You likely can't join if
- Empyema
- Transudate pleural effusion.
- Central airway obstruction by tumor.
- Existence of extensive adhesions that do not allow the development of iatrogenic pneumothorax and the safe entry of the thoracoscope.
- Uncontrollable cough.
- Acute respiratory failure and/or Hypercapnia.
See the full eligibility criteria
- Undiagnosed pleural effusion with the character of a lymphocytic exudate
- Empyema
- Transudate pleural effusion.
- Central airway obstruction by tumor.
- Existence of extensive adhesions that do not allow the development of iatrogenic pneumothorax and the safe entry of the thoracoscope.
- Uncontrollable cough.
- Acute respiratory failure and/or Hypercapnia.
- Performance Status: 5
The study team makes the final eligibility decision.
Where it's taking place
- Athens, Attica, Greece
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Athens, Attica, Greece. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.